Mechanisms of endothelial dysfunction with development of type 1 diabetes mellitus: Role of insulin and C‐peptide
- 26 September 2005
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 96 (6) , 1149-1156
Abstract
Complications associated with insulin‐dependent diabetes mellitus (type‐1diabetes) primarily represent vascular dysfunction that has its origin in the endothelium. While many of the vascular changes are more accountable in the late stages of type‐1diabetes, changes that occur in the early or initial functional stages of this disease may precipitate these later complications. The early stages of type‐1diabetes are characterized by a diminished production of both insulin and C‐peptide with a significant hyperglycemia. During the last decade numerous speculations and theories have been developed to try to explain the mechanisms responsible for the selective changes in vascular reactivity and/or tone and the vascular permeability changes that characterize the development of type‐1diabetes. Much of this research has suggested that hyperglycemia and/or the lack of insulin may mediate the observed functional changes in both endothelial cells and vascular smooth muscle. Recent studies suggest several possible mechanisms that might be involved in the observed decreases in vascular nitric oxide (NO) availability with the development of type‐1 diabetes. In addition more recent studies have indicated a direct role for both endogenous insulin and C‐peptide in the amelioration of the observed endothelial dysfunction. These results suggest a synergistic action between insulin and C‐peptide that facilitates increase NO availability and may suggest new clinical treatment modalities for type‐1 diabetes mellitus.Keywords
This publication has 70 references indexed in Scilit:
- Role of COX-2 in the Enhanced Vasoconstrictor Effect of Arachidonic Acid in the Diabetic Rat KidneyHypertension, 2003
- Two‐chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5The FASEB Journal, 2000
- C-peptide potentiates the vasoconstrictor effect of neuropeptide Y in insulin-dependent diabetic patientsActa Physiologica Scandinavica, 1999
- Vasodilator effect of insulin on the microcirculation of the rat cremaster muscleLife Sciences, 1997
- Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells.Journal of Clinical Investigation, 1996
- Evaluation of the mechanism of endothelial dysfunction in the genetically-diabetic BB ratLife Sciences, 1996
- Nitric oxide release accounts for insulin's vascular effects in humans.Journal of Clinical Investigation, 1994
- Functional changes in vascular smooth muscle and endothelium of arteries during diabetes mellitusLife Sciences, 1992
- Impaired Neurogenic and Endothelium-Mediated Relaxation of Penile Smooth Muscle from Diabetic Men with ImpotenceNew England Journal of Medicine, 1989
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980